PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Medicine10.3904/kjm.2018.93.1.68201893168-73Successful Remission of Recurrent Anaphylaxis after Omalizumab Administration in a Patient with Systemic MastocytosisHongran Moon, Hee Joon Jang, Choon Geun Lee, Young-Chan Kim, Shin Hye Yoo, Dong Soon Lee, Hye-Ryun Kanghttp://ekjm.org/upload/kjm-2018-93-1-68.pdf, http://ekjm.org/journal/view.php?doi=10.3904/kjm.2018.93.1.68, http://ekjm.org/upload/kjm-2018-93-1-68.pdf
Allergy10.1111/j.1398-9995.2007.01604.x2008633376-378ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosisK. Kontou-Filihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1398-9995.2007.01604.x
Annals of Allergy, Asthma & Immunology10.1016/j.anai.2010.04.01120101046537-539Omalizumab monotherapy for bee sting and unprovoked “anaphylaxis” in a patient with systemic mastocytosis and undetectable specific IgEKalliopi Kontou-Fili, Christos I. Filis, Christina Voulgari, Panayiotis G. Panayiotidishttp://api.elsevier.com/content/article/PII:S1081120610004217?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1081120610004217?httpAccept=text/plain
Allergy10.1111/all.132372017731230-238Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observationsS. Broesby-Olsen, H. Vestergaard, C. G. Mortz, B. Jensen, T. Havelund, A. P. Hermann, F. Siebenhaar, M. B. Møller, T. K. Kristensen, C. Bindslev-Jensen, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fall.13237, http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13237/fullpdf
Journal of Allergy and Clinical Immunology10.1016/s0091-6749(03)80711-x20031112S206Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxisC. Akin, D.D. Metcalfehttp://api.elsevier.com/content/article/PII:S009167490380711X?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S009167490380711X?httpAccept=text/plain
Allergy10.1111/j.1398-9995.2009.02259.x2009657926-927Omalizumab is effective in treating systemic mastocytosis in a nonatopic patientJ. A. Douglass, K. Carroll, A. Voskamp, P. Bourke, A. Wei, R. E O’Hehirhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1398-9995.2009.02259.x
American Journal of Hematology10.1002/ajh.243952016917654-655Systemic mastocytosis: evolving lessons from large patient registry datasetsAnimesh Pardananihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fajh.24395
Annals of Allergy, Asthma & Immunology10.1016/j.anai.2014.05.00120141131115-116Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndromeAmanda Jagdis, Peter Vadashttp://api.elsevier.com/content/article/PII:S1081120614002993?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1081120614002993?httpAccept=text/plain
Allergy10.1111/j.1398-9995.2009.02270.x20096581058-1059IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosisA. Matito, B. Bartolomé-Zavala, I. Álvarez-Twose, I. Sánchez-Matas, L. Escribanohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1398-9995.2009.02270.x
Journal of Allergy and Clinical Immunology10.1016/j.jaci.2011.12.51520121292AB103Use of Omalizumab to Achieve Successful Desensitization After Oxaliplatin AnaphylaxisK.N. Cahill, P. Harrison, M. de Asis, M. Castellshttp://api.elsevier.com/content/article/PII:S009167491102478X?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S009167491102478X?httpAccept=text/plain